Company page
Biomark Diagnostics, Inc.
Biomark Diagnostics, Inc. is a public company traded on the Canadian market under the ticker BUX. The company has a market capitalization of approximately CAD 40.1 million. Biomark focuses on developing innovative diagnostic solutions.
- Ticker
- BUX:CSE
- Asset type
- Stock
- Market cap
- $40.1M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- CSE
- Currency
- CAD